HealthcarePsyence Biomedical to acquire drug developer ClairvoyantBy Helitra.com·September 7, 2024·1 min read Psyence Biomedical to acquire drug developer Clairvoyant Source: SeekingalphaADVERTISEMENT ADVERTISEMENTacquire Biomedical Clairvoyant developer drug Psyence Post navigation Previous storyAfya announces MEC decision on medical seats reconsiderationNext storyOrganon downgraded, Amneal upgraded as J.P. Morgan reviews specialty pharma
Fitness · HealthcareThis Exercise Can Help You Build A Sharper Brain In Your 40s & 50sNovember 3, 2026You walk into a room and forget why you’re there. You pause mid-sentence, reaching for a word that used to come easily. Many…
Fitness · HealthcareNew Report: Slippers Cause More Serious Injuries Than Flip-Flops and High HeelsNovember 3, 2026Flip-flops and high heels might seem like the obvious culprits when it comes to footwear-related injuries, but a new analysis suggests Americans should…
Fitness · Healthcare24-Year Study Finds Unexpected Link Between Body Weight and Brain AgingNovember 3, 2026Being overweight can impact more than just your physical health. A new study from the University of Georgia suggests people with a higher…